Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
@Sledgey121: barred from your eyes, but obviously on your mind, enjoy your green fields
@Bushmaster
Abingdon Health : Set of half-year numbers showed revenues rising almost fivefold
SourceBio International: More than doubling of annual revenues to £50.7m
EKF Diagnostics’ (EKF) full-year revenues rose almost a half to £65.3m.
The ABc-19 test was always going to run into problems when the AZ vaccine was able to be manufactured for less than the antibody test that was supposed to accompany it, without MHRA approval for home use its use in the vaccine rollout would push a greater workload onto the nhs staff and delays to the process, we hope now for further use in a surveillance roll, but that is likely to be a very much smaller statistical based use
With regards believing CK,is that his statement with regards to delivering 2m tests a week in April, or the usual statement regarding ramping up capacity but delivering nothing, as we don't have test to produce yet.
You surely have to reflect on their updates through the last 12months and wonder why we are not at an all time high with regards the SP, and have we heard the same narrative before?
Computer909 is currengly barred from my eyes. Does he still have an empty glass or is anything possitive being said. Spare me the low level details :-)
Computer909 - Its hard to argue with the loss of the face of it, it is a loss. What I would say is they have done zero business, is that not down to getting to this point we are today, with everything that has gone on before. For me that is the logical answer. If they had LFTs as Innova had them, then we would be in a different ball. That fact is they didn't, from what I can see no-one in the UK was set up.
The companies you mention, are they in the same industry?
Do you not think the ABC/Antigen was always going to come into play once the vaccine had been given?
Elisa, I take your point.
TT, that has taken a lot longer, why I have no idea. I also think CK is now a lot more cautious in what he states, due to what he said back in Nov/Dec, pushed by CK the TT would be done early on in the new year. I think he has learnt from that, best say nothing until its done. Its been a big stick used by many to hit the company with, which has effected the SP, I don't think anyone can argue with that.
Apart from the TT, Elisa, a few others come to mind, I can't see how this has come up short. I can see the frustration, but as I said on the earlier post, a lot has taken place in 12 months. We either believe in what CK says, ie: contracts, production at 2 mil a week or not, that is the botton line.
We also don't know what stock has been manufactured, what tests and how much they are sitting on in stock, if any. Depending on what you believe and read on various boards etc, its not a lot, or close to 10 million - If this is the case, would it been better to of sold what is (if) being produced and let us shareholders know, maybe, would the SP be in a better postion, no idea.
I don't know what the CK business model/plan is that has got them to where they are today, but we either trust them or we sell out, its one or the other until the RNS's drop.
@Bushmaster: A reported loss of £2.3m in the year of a pandemic by world leading diagnostics company in the middle of a pandemic when like companies have increased their revenue by multiples, £11m cash injection in order to exploit Covid opportunities nearly a year ago, zero contracts in place to actually manufacture anything.
Abc-19 estimated of 200,000 tests a week, total sales 175k
Elisa estimated o 46,000 tests a day, next to nothing sold
Visitect Antibody test, no mention of anything and they cant even supply a single distributor contact details
I’ll allow them a pause for Cd4 and food tolerance due to the pandemic
4 months for Tech transfer, we wait to hear regards the interested parties after launch, whenever that is actually achieved
When have we actually not come up short?
https://twitter.com/sharebuyers/status/1383725359674261507?s=19
If Bigjock36’s communications with Colin King are fictitious, then surely ODX/Walbrook would not remain silent?
Once ODX get through this period, the market will focus on the future, at what an utter transformation of revenues ODX have managed to achieve. Then there is all the other news form other products to look forward too, and new markets for its own branded LFT....plus a possible expansion in production of LFTs by 25%, 50% , who knows.
Its going to be a good summer this summer in ODX.
We are in the absolute infancy of testing.
If we are no longer using lockdown as an option in the future, it’s going to be a necessity to be tested frequently if you want to live as normal a life as possible to be able to attend events back to capacity or travel as usual to keep your freedom of movement you will be required to prove evidence you don’t have covid, that is a fact.
With the added worry of the vaccines maybe not having as good an affect stopping the spread & new variants & mutations continuing the spread if we were to have mini lockdowns to control new upcoming waves, testing will be continuous for many many years. I can see a stockpile of LFTs needed. I think there’s a possibility we will have to double or maybe triple capacity of manufacturing going forward next year. Would not surprise me if we here these sought of announcements late summer & extended contracts with the dhsc on top of our initial £374m for next year.
Vascular, good post.
Computer909, I am struggling to understand why Omega have come up short, time and time again? Its more or less 12 months since Covid hit, they had no postion to manufacture, no machines, no staff to deal with the demand, no nothing. So in 12 months they have gone from zero to where we are today. If this was going on for years like a lot of other companies, granted, I get your point, but its 12 months.
From a pure business point of view that is pretty dam good, considering we think/been told there are big contract (s) coming in. You can argue all day long about communication, but 12 months to set all of this up, recruiting, new building, new machines, new suppliers, contract negotiations etc etc...I think they have done pretty well.
@Bedhead: Totally agree if you had invested exactly a year ago (or a little before) you would have multi-bagged on the back of the UK-RTC news and the promise of increasing revenue due to our position in the consortium and the opportunity it afforded us, but if you consider the growth from getting in just two weeks later (the end of April 2020) the return would be 30%, fantastic some would say, but how much of that return is now built on the fear of missing out from holders that have heard it all before from a company that simply comes up short time and time again?
Bedhead great post, the green boxes won’t like that and Colin answered many questions(sharebuyers) with positive answers a few days ago.
Ps bigjock keep up the good work
Positive news flow is around the corner anytime, we’ve had positive news from CK in the covid fight since last march hence the SP already multibagging from single digit to triple digit, (soon be back in triple digits!)we’ve been lining all our ducks in a row, increase in machinery, increase in staff, contract with DHSC....them giving us machinery ready for the upcoming covid wartime manufacturing of homegrown gold standard LFTs to help open up the economy-
If you can’t add up all the dots with announcements & Q&As already out there to see that this is a clear triple digit SP then your not seeing through all the de ramping nonsensical claptrap. How clearer do you want it....
CK - Transformational year for ODX!!
Government cant have no more lockdowns...hence largest vaccine rollout in history, with the largest testing programme only just in its infancy as we’ve been preparing for this summer for a year now...THE TIME HAS COME .. THE COUNTRY HAS BEEN IDLING ALONG.. It needs help going through the gears to be cruising down the motorway in 6th gear again... TO BUSINESS AS USUAL EVERYTHING FULL CAPACITY ....LIFE BACK TO NORMAL. I’d say for this to happen we are going to be having to get used to proof of LFT results or many years to come for this to happen.
ODX are at the centre of this in the UK....Would not surprise me to see a £1billion market cap incoming
Maninpink.
Behind the scenes Omega are still recruiting!
https://www.jobsitejobs.co.uk/company/53697/omega-diagnostics-ltd/
Look like quality control employees.
No one really knows whats going on behind the scenes . There is to many clues to know it is coming sooner or later I ignor a lot of what is written on here as im happy to wait .. 12 months now Good luck all
Thanks Bluekipper12,
I'm of an age to remember buying shares and having to wait till the evening standard was printed later that same day to get the SP, yes antiquated BUT it was simple, and you did not have online BBs, with peeps giving out all sorts of mis information and screwing with your head. You relied on the RNS, the quality of the board, contact with the company and your own instincts. I imagine even fever tree ( everyone quotes a success story these days) had a loyal following of peeps who did nothing but belittle the company's performance.
Great summary Vascular.
I think most investors know that ODX have the contracts to supply the government, and will gain further contracts to supply their independent LFT to whoever, but the delays ( is it a delay, only in mid April), news blackout has caused a void which has thrown up uncertainty and given many carte blanche to say whatever they wish. The lack of news means it is really hard to defend the company by the loyal supporters, which makes more investors nervous.
If you go by the RNSs, read Big Jocks communications with both eyes open, you will see that very little if anything that is stated by Big Jock , isn't already written in an RNS. If you agree,and re read RNS's and BJs posts then its as clear as it can be to me that ODX will succeed, use their full capacity and will consider further expanding once the 200 m production is settled.
IMO from todays SP a doubling in share price between now and then is pretty much expected, after that there should be a great deal more. IMO everything will fall into place over the next two weeks, and probably be a three buses in a row scenario.
.. Big Jock for your posts. I'm a simple bloke, invest my hard earnt and appreciate your posts.